309 related articles for article (PubMed ID: 11802014)
1. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study.
Noordzij JP; Khidr A; Evans BA; Desper E; Mittal RK; Reibel JF; Levine PA
Laryngoscope; 2001 Dec; 111(12):2147-51. PubMed ID: 11802014
[TBL] [Abstract][Full Text] [Related]
2. Correlation of pH probe-measured laryngopharyngeal reflux with symptoms and signs of reflux laryngitis.
Noordzij JP; Khidr A; Desper E; Meek RB; Reibel JF; Levine PA
Laryngoscope; 2002 Dec; 112(12):2192-5. PubMed ID: 12461340
[TBL] [Abstract][Full Text] [Related]
3. Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study.
Wo JM; Grist WJ; Gussack G; Delgaudio JM; Waring JP
Am J Gastroenterol; 1997 Dec; 92(12):2160-5. PubMed ID: 9399745
[TBL] [Abstract][Full Text] [Related]
4. Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial.
El-Serag HB; Lee P; Buchner A; Inadomi JM; Gavin M; McCarthy DM
Am J Gastroenterol; 2001 Apr; 96(4):979-83. PubMed ID: 11316215
[TBL] [Abstract][Full Text] [Related]
5. Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis.
Williams RB; Szczesniak MM; Maclean JC; Brake HM; Cole IE; Cook IJ
Am J Gastroenterol; 2004 May; 99(5):777-85. PubMed ID: 15128336
[TBL] [Abstract][Full Text] [Related]
6. Chronic laryngitis associated with gastroesophageal reflux: prospective assessment of differences in practice patterns between gastroenterologists and ENT physicians.
Ahmed TF; Khandwala F; Abelson TI; Hicks DM; Richter JE; Milstein C; Vaezi MF
Am J Gastroenterol; 2006 Mar; 101(3):470-8. PubMed ID: 16542282
[TBL] [Abstract][Full Text] [Related]
7. [Manifestations of gastroesophageal reflux in the otorhinolaryngology tract].
Issing WJ; Gross M; Tauber S
Laryngorhinootologie; 2001 Aug; 80(8):464-9. PubMed ID: 11552426
[TBL] [Abstract][Full Text] [Related]
8. Treatment of postnasal drip with proton pump inhibitors: a prospective, randomized, placebo-controlled study.
Pawar S; Lim HJ; Gill M; Smith TL; Merati A; Toohill RJ; Loehrl TA
Am J Rhinol; 2007; 21(6):695-701. PubMed ID: 18201449
[TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic posterior laryngitis with esomeprazole.
Vaezi MF; Richter JE; Stasney CR; Spiegel JR; Iannuzzi RA; Crawley JA; Hwang C; Sostek MB; Shaker R
Laryngoscope; 2006 Feb; 116(2):254-60. PubMed ID: 16467715
[TBL] [Abstract][Full Text] [Related]
10. [Impact of 24-hour intraesophageal pH monitoring with 2 channels in the diagnosis of reflux-induced otolaryngologic disorders].
Issing WJ; Tauber S; Folwaczny C; Reichel O
Laryngorhinootologie; 2003 May; 82(5):347-52. PubMed ID: 12800080
[TBL] [Abstract][Full Text] [Related]
11. Predictors of response to short-term proton pump inhibitor treatment in laryngopharyngeal reflux patients.
Siupsinskiene N; Adamonis K; Toohill RJ; Sereika R
J Laryngol Otol; 2008 Nov; 122(11):1206-12. PubMed ID: 18331659
[TBL] [Abstract][Full Text] [Related]
12. Symptoms, laryngeal findings, and 24-hour pH monitoring in patients with suspected gastroesophago-pharyngeal reflux.
Ylitalo R; Lindestad PA; Ramel S
Laryngoscope; 2001 Oct; 111(10):1735-41. PubMed ID: 11801936
[TBL] [Abstract][Full Text] [Related]
13. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG
Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
[TBL] [Abstract][Full Text] [Related]
14. Posterior laryngitis: effects of treatment with omeprazole alone.
Rodríguez-Téllez M; Galera-Ruiz H; Argüelles-Arias F; Carmona I; Muñoz-Borje F; Herrerías JM
Rev Esp Enferm Dig; 2002 Mar; 94(3):123-30. PubMed ID: 12185876
[TBL] [Abstract][Full Text] [Related]
15. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough.
Ours TM; Kavuru MS; Schilz RJ; Richter JE
Am J Gastroenterol; 1999 Nov; 94(11):3131-8. PubMed ID: 10566703
[TBL] [Abstract][Full Text] [Related]
16. Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.
Baldi F; Morselli-Labate AM; Cappiello R; Ghersi S;
Am J Gastroenterol; 2002 Jun; 97(6):1357-64. PubMed ID: 12094850
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
Lizogub VG; Riley DS; Heger M
Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
[TBL] [Abstract][Full Text] [Related]
18. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
Bautista J; Fullerton H; Briseno M; Cui H; Fass R
Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202
[TBL] [Abstract][Full Text] [Related]
19. Correlation between symptoms and laryngeal signs in laryngopharyngeal reflux.
Qadeer MA; Swoger J; Milstein C; Hicks DM; Ponsky J; Richter JE; Abelson TI; Vaezi MF
Laryngoscope; 2005 Nov; 115(11):1947-52. PubMed ID: 16319603
[TBL] [Abstract][Full Text] [Related]
20. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
Pfefferkorn MD; Croffie JM; Gupta SK; Molleston JP; Eckert GJ; Corkins MR; Fitzgerald JF
J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):160-5. PubMed ID: 16456408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
